Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Phenobarbital 5mg/5ml oral liquid
0408010N0AADJDJ
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 60mg capsules
0408010N0AAAVAV
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 60mg/5ml oral liquid
0408010N0AADWDW
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 62.5mg/5ml oral liquid
0408010N0AACQCQ
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 65mg/5ml oral liquid
0408010N0AAELEL
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 7.5mg/5ml oral liquid
0408010N0AAEKEK
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 70mg/5ml oral liquid
0408010N0AADHDH
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 72.5mg/5ml oral liquid
0408010N0AAEIEI
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 80mg/5ml oral liquid
0408010N0AAEJEJ
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 85mg/5ml oral liquid
0408010N0AADCDC
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 9.5mg/5ml oral liquid
0408010N0AADLDL
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital 9mg/5ml oral liquid
0408010N0AAEMEM
|
Phenobarbital | Phenobarbital | Central Nervous System | No data available |
|
Phenobarbital sodium 100mg/5ml oral liquid
0408010P0AABHBH
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 10mg/5ml oral liquid
0408010P0AABBBB
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 11mg/5ml oral liquid
0408010P0AABFBF
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 125mg/5ml oral liquid
0408010P0AABABA
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 15mg/5ml oral liquid
0408010P0AAAYAY
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 17mg/5ml oral liquid
0408010P0AABGBG
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 30mg/5ml oral liquid
0408010P0AABCBC
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 35mg/5ml oral liquid
0408010P0AABLBL
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 36mg/5ml oral liquid
0408010P0AABEBE
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 45mg/5ml oral liquid
0408010P0AABMBM
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 55mg/5ml oral liquid
0408010P0AABNBN
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 5mg/5ml oral liquid
0408010P0AABPBP
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
|
Phenobarbital sodium 60mg/5ml oral liquid
0408010P0AAAZAZ
|
Phenobarbital sodium | Phenobarbital sodium | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.